145 related articles for article (PubMed ID: 3871932)
1. [HLA and myasthenia. Subdivision in 3 categories].
Elchidiac A; Lepage V; Berrih S; Colombani J; Degos L
Pathol Biol (Paris); 1985 Jan; 33(1):50-4. PubMed ID: 3871932
[TBL] [Abstract][Full Text] [Related]
2. HLA antigens and susceptibility to myasthenia gravis.
Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
[TBL] [Abstract][Full Text] [Related]
3. [Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters].
Grosse-Wilde H; Toyka KV; Besinger UA; Doxiadis I; Heininger K; Hömberg M; Hömberg V; Hohlfeld R; Fateh-Moghadam A; Jungwirth J; Kreeb G; Vögeler U
Dtsch Med Wochenschr; 1983 May; 108(18):694-700. PubMed ID: 6839994
[TBL] [Abstract][Full Text] [Related]
4. [HLA typing and insulin antibody production in insulin-dependent diabetics].
Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
[TBL] [Abstract][Full Text] [Related]
5. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.
Garlepp MJ; Dawkins RL; Christiansen FT
Br Med J (Clin Res Ed); 1983 Jan; 286(6362):338-40. PubMed ID: 6402089
[TBL] [Abstract][Full Text] [Related]
6. [Subgroups of myasthenia gravis. Association of the early form with HLA B8/DR3].
Scherbaum WA; Schumm F
Dtsch Med Wochenschr; 1983 Aug; 108(31-32):1218. PubMed ID: 6575909
[No Abstract] [Full Text] [Related]
7. Immunogenetics and immunopathology of human primary membranous glomerulonephritis: HLA-A, B, DR antigens; functional activity of splenic macrophage Fc-receptors and peripheral blood T-lymphocyte subpopulations.
Berthoux FC; Laurent B; le Petit JC; Genin C; Broutin F; Touraine F; Hassan AA; Champailler A
Clin Nephrol; 1984 Jul; 22(1):15-20. PubMed ID: 6236923
[TBL] [Abstract][Full Text] [Related]
8. [Biermer's anemia, Hashimoto's thyroiditis, myasthenia and malignant thymoma. HLA B8, DR3, and DR5 antigens].
Humbert P; Dupond JL; Mallet H; Leconte des Floris R
Presse Med; 1984 Feb; 13(7):439. PubMed ID: 6230615
[No Abstract] [Full Text] [Related]
9. Studies on HLA antigens and cellular and humoral autoimmune phenomena in patients with myasthenia gravis.
Gross WL; Krüger J; Gröschel-Stewart U; Friedrich H; Kunze K
Clin Exp Immunol; 1977 Jan; 27(1):48-54. PubMed ID: 849650
[TBL] [Abstract][Full Text] [Related]
10. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
[TBL] [Abstract][Full Text] [Related]
11. Immunogenetics and immunopathology of human membranous glomerulonephritis.
Laurent B; Berthoux FC; Le Petit JC; Genin G; Laurent P; Broutin F; Touraine F; Touraine JL
Proc Eur Dial Transplant Assoc; 1983; 19():629-34. PubMed ID: 6410385
[TBL] [Abstract][Full Text] [Related]
12. Myasthenia gravis and HLA antigens in American blacks and other races.
Christiansen FT; Pollack MS; Garlepp MJ; Dawkins RL
J Neuroimmunol; 1984 Dec; 7(2-3):121-9. PubMed ID: 6334696
[TBL] [Abstract][Full Text] [Related]
13. HLA antigens of insulin-dependent diabetics. I. PLT colonies detecting Dw10 and a new class II determinant distinct from HLA-D, DR, MB(DC), MT, and SB.
Sheehy MJ; Quintieri FB; Yang SY; Alosco SM; Matsui Y; Yunis EJ; Gabbay KH
Tissue Antigens; 1984 May; 23(5):290-300. PubMed ID: 6205468
[TBL] [Abstract][Full Text] [Related]
14. HLA antigens and myasthenia gravis in north India.
Mehra NK; Ahuja GK; Taneja V; Vaidya MC
J Neurol Neurosurg Psychiatry; 1983 Apr; 46(4):361-4. PubMed ID: 6842252
[TBL] [Abstract][Full Text] [Related]
15. Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5.
Niks EH; Kuks JB; Roep BO; Haasnoot GW; Verduijn W; Ballieux BE; De Baets MH; Vincent A; Verschuuren JJ
Neurology; 2006 Jun; 66(11):1772-4. PubMed ID: 16769963
[TBL] [Abstract][Full Text] [Related]
16. Antiacetylcholine receptor and antinuclear antibodies in myasthenia gravis. Correlation with HLA, sex and Gm.
Warlow RS; Garlepp M; Feeney D; Kay P; Swanson N; Dawkins RL
Exp Clin Immunogenet; 1985; 2(3):158-63. PubMed ID: 3917146
[TBL] [Abstract][Full Text] [Related]
17. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR associations with Graves' disease in eastern Hungary.
Stenszky V; Kozma L; Balazs C; Farid NR
Clin Invest Med; 1983; 6(3):181-4. PubMed ID: 6580983
[TBL] [Abstract][Full Text] [Related]
19. HLA antigens in systemic lupus erythematosus: relationship to disease severity, age at onset, and sex.
Bell DA; Rigby R; Stiller CR; Clark WF; Harth M; Ebers G
J Rheumatol; 1984 Aug; 11(4):475-9. PubMed ID: 6332909
[TBL] [Abstract][Full Text] [Related]
20. (T,G)-A-L specific immune response potential and HLA typing of Israeli patients with systemic lupus erythematosus.
Shalev Y; Bentwich Z; Katz D; Brautbar C; Mozes E
Clin Exp Immunol; 1985 May; 60(2):355-62. PubMed ID: 2408803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
